Hostname: page-component-745bb68f8f-grxwn Total loading time: 0 Render date: 2025-02-02T23:37:40.846Z Has data issue: false hasContentIssue false
  • English
  • Français

Clinical Trypanosoma rangeli infection as a complication of Chagas‘ disease

Published online by Cambridge University Press:  06 April 2009

F. Guhl ,
L. Hudson ,
C. J. Marinkelle ,
C. A. Jaramillo  and
D. Bridge
F. Guhl
Affiliation:
Departamento de Ciencias Biologicas, Universidad de los Andes, Bogota, D.E., Colombia
L. Hudson*
Affiliation:
Department of Immunology, St George's Hospital Medical School, Cranmer Terrace, London SW17 0RE
C. J. Marinkelle
Affiliation:
Departamento de Ciencias Biologicas, Universidad de los Andes, Bogota, D.E., Colombia
C. A. Jaramillo
Affiliation:
Departamento de Ciencias Biologicas, Universidad de los Andes, Bogota, D.E., Colombia
D. Bridge
Affiliation:
Department of Immunology, St George's Hospital Medical School, Cranmer Terrace, London SW17 0RE
*
*Reprint requests: Professor L. Hudson, Department of Immunology, St George's Hospital Medical School, Cranmer Terrace, London SW17 0RE.
Get access Rights & Permissions [Opens in a new window]

Extract

Laboratory studies on a group of 20 patients from the Rio Negro Valley, Colombia selected for detailed study showed that 14 gave antibody reactions on immunoassay consistent with Trypanosoma cruzi or T. rangeli infections. Four were diagnosed as having T. rangeli infection, 4 had mixed infections and 6 were infected with T. cruzi alone. Immunoprecipitation analysis showed that sera from T. crwzi-infected patients recognized a similar range of trypomastigote-derived polypeptides as sera from patients in Brazil, and all of the Colombian sera reacted with the 160 kiloDalton (kDa) polypeptide associated with active infection. Although sera from patients with T. rangeli infection alone gave a positive immunofluorescence or ELISA reaction with T. rangeli, they failed to bind to parasite polypeptides by either immunoprecipitation or Western blotting. Intriguingly, sera from patients with mixed infections consistently gave a stronger, but qualitatively similar, binding reaction in immunoprecipitation and Western blotting compared to sera from patients infected with T. cruzi alone.

Type
Research Article
Information
Parasitology , Volume 94 , Issue 3 , June 1987 , pp. 475 - 484
Copyright
Copyright © Cambridge University Press 1987

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Afchain, D., LeRay, D., Fruit, J. & Capron, A. (1979). Antigenic makeup of Trypanosoma cruzi culture forms: identification of a specific component. Journal of Parasitology 65, 507–14.CrossRefGoogle ScholarPubMed
D'Alessandro, A. (1972). New experimental vectors of Colombian Trypanosoma rangeli. Journal of Medical Entomology 9, 189–95.CrossRefGoogle ScholarPubMed
D'Alessandro, A. (1974). El problema de la enfermedad de Chagas en eh hemisferio occidental. Boletin de la Oficina Sanitaria Panamericana 76, 242–7.Google Scholar
D'Alessandro, A. (1976). Biology of Trypanosoma (Herpetosoma) rangeli. Tejera, 1920. In Biology of the Kinetoplastida, vol. 1, (ed. Lumsden, W. H. R. and Evans, D. A.), pp. 329–93. New York: Academic Press.Google Scholar
Ferguson, M. A. J., Allen, A. K. & Snary, D. (1983). Studies on the structure of a phosphoglyco-protein from the parasitic protozoan Trypanosoma cruzi. The Biochemical Journal 213, 313–19.CrossRefGoogle ScholarPubMed
Guhl, F., Hudson, L., Marinkelle, C. J., Morgan, S. J. & Jaramillo, C. (1985). Antibody response to experimental Trypanosoma rangeli infection and its implications for immunodiagnosis of South American trypanosomiasis. Acta Tropica 42, 311–18.Google ScholarPubMed
Guhl, F. & Marinkelle, C. J. (1982). Antibodies against Trypanosoma cruzi in mice infected with T. rangeli. Annals of Tropical Medicine and Parasitology 76, 361.CrossRefGoogle ScholarPubMed
Guhl, F., Marinkelle, C. J., Gonzalez, A. & de Sanchez, N. (1987). Contribucion al estudio de la enfermedad de Chagas en un area endemica al oriente de la cnidad de Bogatá. Boletin de la Oficina Sanitaria Panamerica (In the Press).Google Scholar
Hudson, L. & Britten, V. (1985). Immune response to South American trypanosomiasis and its relationship to Chagas' disease. British Medical Bulletin 41, 175–80.CrossRefGoogle ScholarPubMed
Krettli, A. U. & Brener, Z. (1982). Resistance against Trypanosoma cruzi associated to anti-living trypomastigote antibodies. Journal of Immunology 128, 2009–12.CrossRefGoogle ScholarPubMed
Martins, M. S., Hudson, L., Krettli, A. U., Cançado, J. R. & Brener, Z. (1985). Human and mouse sera recognise the same polypeptide associated with immunological resistance to Trypanosoma cruzi infection. Clinical and Experimental Immunology 61, 343–50.Google ScholarPubMed
Schechter, M., Flint, J. E., Voller, A., Guhl, F., Marinkelle, C. J. & Miles, M. A. (1983). Purified Trypanosoma cruzi specific glycoprotein for discriminative serological diagnosis of South American trypanosomiasis (Chagas' disease). Lancet 2, 939–41.CrossRefGoogle ScholarPubMed
Sher, A. & Snary, D. (1982). Specific inhibition of the morphogenesis of Trypanosoma cruzi by a monoclonal antibody. Nature, London 300, 639–40.CrossRefGoogle ScholarPubMed
Snary, D. & Hudson, L. (1979). T. cruzi cell surface proteins: identification of one major glycoprotein. FEBS Letters 100, 166–70.CrossRefGoogle Scholar
Towbin, H., Stahelin, T. & Gordon, J. (1979). Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proceedings of the National Academy of Sciences, USA 76, 4350–4.CrossRefGoogle ScholarPubMed
Wong, R. C. K., Hudson, L. & Hindmarsh, P. J. E. (1986). Immune precipitation and immunoblotting for the detection of Trypanosoma cruzi antigens. Transactions of the Royal Society of Tropical Medicine and Hygiene 80, 275–81.CrossRefGoogle ScholarPubMed